This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Mallinckrodt purchases pain drug Roxicodone from Xanodyne
24 Aug 2012
Continuing to strengthen its portfolio in preparation for a spin off from Covidien PLC’s Covidien Ltd., Mallinckrodt LLC (branded and generic pain and addiction treatments) has acquired Roxicodone (oxycodone, 5, 15, and 30 mg dosages) from Xanodyne Pharmaceuticals Inc. (formerly focused on pain management). The transaction includes all rights to the drug’s NDA.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?